Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
WUXI Series Collectively Mount as WUXI XDC Wins 4 Awards at Asia-Pacific Biopharma Excellence Awards 2025
Recommend 28 Positive 48 Negative 15 |
||||
|
||||
|
WUXI series were popular this morning (14th). WUXI XDC (02268.HK) surged nearly 10% to $38.55, while WUXI BIO (02269.HK) spiked 10.3% to $25.7. WUXI APPTEC (02359.HK) leaped 4.2%. WUXI XDC won 4 awards at Asia-Pacific Biopharma Excellence Awards 2025, as announced by WUXI XDC. The Asia-Pacific Biopharma Excellence Awards honor companies annually that have exhibited outstanding performance and achievement in the biopharmaceutical industry. This series of awards underscore WUXI XDC's technology leadership in ADCs, the Company's integrated CRDMO capabilities from early discovery to commercial manufacturing, and WUXI XDC's commitment to continuously empowering its global clients with high-quality services. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
